HENWOOD GERALDINE (President and CEO) received a stock award from BAUDAX BIO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/17/2022ACC: 0001062993-22-015123
DirectorOfficer· President and CEO
Since Nov 2019
+39.47K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
39.47K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39.47K
Price / share
—
Trade value
—
% of position
410.3%
6/15/2022
9.62K→49.09K
Total
Net shares
+39.47K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2022 | A · Award | +39.47K | — | — | 410.3% | 9.62K | 49.09K |
| Total | +39.47K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned571.00
Total
571.00 indirect571.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 571.00 | Indirect |
| Total | 571.00 | 571.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported